Improved Rate Control Reduces Cardiac Troponin T Levels in Permanent Atrial Fibrillation
Authors:
- 3 April 2014
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 37 (7) , 422-427
Abstract
Background: Detectable levels of troponins are often found in serum of patients with atrial fibrillation (AF), and recent reports suggest that Tn concentrations are independently related to patient prognosis.Hypothesis: We hypothesized that treatment with common rate‐reducing drugs might lower the levels of cardiac troponin T (TnT) in patients with permanent AF. We also wanted to investigate whether the different drugs would impact the Tn levels differently.Methods: Sixty patients were included (mean age 71 ± 9 years, 18 women) in this randomized crossover study. All patients had stable, permanent AF without ischemic heart disease or congestive heart failure. Diltiazem 360 mg, verapamil 240 mg, metoprolol 100 mg, and carvedilol 25 mg were administered once daily for 3 weeks, in a randomized sequence. At baseline and on the last day of each treatment period, TnT concentrations were measured at rest and after a maximal exercise test.Results: TnT was detectable in all patients. In 22% of the patients, TnT concentrations were above the threshold normally used for diagnosing myocardial infarction. All drugs reduced the levels of TnT significantly compared with baseline (P < 0.001 for all), but there were no significant differences between the treatments. Levels of TnT increased significantly in response to exercise testing (P < 0.001 for all).Conclusions: Elevated TnT was demonstrated in a large proportion of stable patients with permanent AF without ischemic heart disease. A moderate reduction of heart rate by the study drugs was associated with a significant reduction in levels of TnT.Keywords
Funding Information
- Medical Research Foundation, B�rum Hospital, Norway
- South-Eastern Norway Regional Health Authority
This publication has 28 references indexed in Scilit:
- High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or WarfarinJACC, 2014
- Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery DiseaseJACC, 2013
- Comparison of Four Single-Drug Regimens on Ventricular Rate and Arrhythmia-Related Symptoms in Patients With Permanent Atrial FibrillationThe American Journal of Cardiology, 2013
- High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillationJournal of Thrombosis and Haemostasis, 2012
- Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial FibrillationCirculation, 2012
- New sensitive cardiac troponin assays for the early diagnosis of myocardial infarctionDrugs of Today, 2011
- Lenient versus Strict Rate Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2010
- Frequency of Elevated Troponin I and Diagnosis of Acute Myocardial InfarctionThe American Journal of Cardiology, 2009
- Elevated troponin level is not synonymous with myocardial infarctionInternational Journal of Cardiology, 2006
- Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old MenCirculation, 2006